Several niche corners of the US stock market are undergoing the most significant overhaul in recent years. According to people familiar with the matter, internal communications at a handful of mid-cap and specialized companies point to accelerated strategic shifts, ranging from divestments to defense supply chain expansions. I'm told that executives are pushing to finalize these transitions before the next earnings cycle.

Vital Farms (VITL.US)

The ethically sourced food brand has seen mixed performance recently. Behind the scenes, I’m told the company is executing a definitive pivot to phase out its butter business by the end of fiscal 2026. Gross margins shrank to 28.3% in Q1 2026 amid intensified egg industry competition. To stabilize expectations, the firm is working through inventory and has repurchased USD 20M worth of shares.

Landos Biopharma (LBRX.US)

The clinical-stage biopharma space saw a notable exit recently. AbbVie’s acquisition of Landos Biopharma for approximately USD 137.5M was completed in Q2 2024. The move hands AbbVie control of NX-13, an oral therapy currently advancing through Phase II trials in the US and Europe, effectively closing the book on Landos as an independent entity.

The Elmet Group (ELMT.US)

The precision engineering supplier has outperformed many peers following a recent IPO. According to sources close to the US Department of Defense supply chain, Elmet secured a USD 4.3M contract in June 2026 to expand domestic production of molybdenum-based components. With Q1 2026 revenue jumping 20.7% to USD 56M, the company also deepened its critical supply chain footprint by acquiring 20 million shares of EQ Resources.

Intellinetics (INTT.US)

Intellinetics is navigating a painful transition period this month. Total revenue slipped 8.0% to USD 3.9M in the first quarter of 2026. However, I am told management remains laser-focused on accelerating its Software as a Service (SaaS) pipeline, targeting double-digit growth for the segment throughout fiscal 2026.

AMTD Digital (HKD.US)

AMTD’s hospitality and digital media arm is steadily expanding its global footprint. The company issued a positive revenue alert for the first half of 2026, driven largely by the integration of four newly acquired hotels. Furthermore, the board of its subsidiary TGE approved a stock buyback program worth up to USD 10M earlier this summer.

Also

• AGM Group Holdings (AGMH.US): The Hong Kong-based company continues to navigate the volatile cryptocurrency mining equipment and custom ASIC chip markets.
• Here Technologies (HERE.US): I'm told its subsidiary successfully converted an evaluation agreement into a commercial licensing deal in August 2026 to power truck routing software.
• Vanguard Intermediate-Term Treasury ETF (VGIT.US) & Franklin FTSE Brazil ETF (FLBR.US): Amid shifting global yields, VGIT remains a primary tool for intermediate US Treasury exposure, while FLBR continues tracking the Brazilian equity market for regional investors.

This article does not constitute investment advice.